1. Home
  2. CLDX vs KYN Comparison

CLDX vs KYN Comparison

Compare CLDX & KYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Celldex Therapeutics Inc.

CLDX

Celldex Therapeutics Inc.

HOLD

Current Price

$25.87

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Logo Kayne Anderson Energy Infrastructure Fund Inc.

KYN

Kayne Anderson Energy Infrastructure Fund Inc.

HOLD

Current Price

$11.86

Market Cap

2.0B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLDX
KYN
Founded
N/A
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.0B
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
CLDX
KYN
Price
$25.87
$11.86
Analyst Decision
Buy
Analyst Count
10
0
Target Price
$44.10
N/A
AVG Volume (30 Days)
718.4K
561.5K
Earning Date
11-10-2025
01-01-0001
Dividend Yield
N/A
8.99%
EPS Growth
N/A
N/A
EPS
N/A
0.71
Revenue
$2,599,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$19.70
N/A
P/E Ratio
N/A
$13.79
Revenue Growth
N/A
N/A
52 Week Low
$14.40
$7.84
52 Week High
$30.50
$9.88

Technical Indicators

Market Signals
Indicator
CLDX
KYN
Relative Strength Index (RSI) 44.96 44.87
Support Level $24.97 $11.59
Resistance Level $28.79 $12.52
Average True Range (ATR) 1.36 0.21
MACD -0.36 -0.07
Stochastic Oscillator 16.46 25.81

Price Performance

Historical Comparison
CLDX
KYN

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

About KYN Kayne Anderson Energy Infrastructure Fund Inc.

Kayne Anderson Energy Infrastructure Fund, Inc is a non-diversified, closed-end fund. Its investment objective is to provide a high after-tax total return with an emphasis on making cash distributions to the stockholder. The Company invests in various sectors, which include midstream energy companies, renewable infrastructure companies, and utility companies. The company seeks to achieve its objectives by investing a majority of its total assets in the securities of Energy Infrastructure companies.

Share on Social Networks: